It was reported that ATF3 could predict whether tumors were sensitive to histone deacetylase inhibitors, and ATF3 played an important role in the apoptosis of tumor cells caused by histone deacetylase inhibitors through transcriptionally inhibiting pro-survival factor BCL-XL4 [36]. This evidence concerns the gene ATF3 and neoplasm.